Real-world evidence: experiences and challenges for decision making in Latin America

被引:3
作者
Garcia Marti, Sebastian [1 ]
Pichon-Riviere, Andres [1 ]
Augustovski, Federico [1 ]
Espinoza, Manuel [2 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, Inst Clin Effectiveness & Hlth Policy IECS, Buenos Aires, Argentina
[2] Pontificia Univ Catolica Chile, Sch Med, Dept Publ Hlth, Santiago, Chile
关键词
real-world data; real-world evidence; technology assessment; Latin America; coverage;
D O I
10.1017/S0266462323002647
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ObjectiveThe Health Technology Assessment (HTA) process aims to optimize health system funding of technologies. In recent years there has been an increase in what is known as Real-World Evidence (RWE) as a complement to clinical trials. The objective of Health Technology Assessment International's Latin American Policy Forum 2022 was to explore the utility of incorporating RWE into HTA and decision-making processes in the region.MethodsThis article is based on a background document, survey, and the deliberative work of the country representatives who participated in the Forum.ResultsThere is a growing interest in the use of Real-World Data / Real-World Evidence in HTA processes in Latin America, although currently there are no specific local guidelines for RWE use by HTA agencies. At present, its use is limited to certain areas such as adding context to HTA reports, the evaluation of adverse events, or cost estimation.Potential future uses of RWE were identified, including the creation of risk-sharing agreements, the assessment of technology performance in routine practice, providing information on outcomes that are not so easily evaluated in clinical trials (e.g., the identification of specific subpopulations or quality of life), and the estimation of input parameters for economic evaluations.ResultsThere is a growing interest in the use of Real-World Data / Real-World Evidence in HTA processes in Latin America, although currently there are no specific local guidelines for RWE use by HTA agencies. At present, its use is limited to certain areas such as adding context to HTA reports, the evaluation of adverse events, or cost estimation.Potential future uses of RWE were identified, including the creation of risk-sharing agreements, the assessment of technology performance in routine practice, providing information on outcomes that are not so easily evaluated in clinical trials (e.g., the identification of specific subpopulations or quality of life), and the estimation of input parameters for economic evaluations.ConclusionsThe participants agreed that there are several areas presenting significant potential to expand the application of RWD/RWE and that the development of normative frameworks for its use could be helpful.
引用
收藏
页数:6
相关论文
共 15 条
[1]  
Annemans L., The use of real world data throughout an innovative medicine's lifecycle
[2]  
Brown T, 2012, Design thinking
[3]   Real-World Evidence for Regulatory Decision-Making: Guidance From Around the World [J].
Burns, Leah ;
Le Roux, Nadege ;
Kalesnik-Orszulak, Robert ;
Christian, Jennifer ;
Hukkelhoven, Mathias ;
Rockhold, Frank ;
O'Donnell, John .
CLINICAL THERAPEUTICS, 2022, 44 (03) :420-437
[4]  
chathamhouse, Chatham House Rule | Chatham House
[5]  
Costa L, 2021, VALUE HEALTH, V24, pS194
[6]  
Garcia Marti S, Evidencia del Mundo Real (Real World Evidence): Experiencias y desafios para la toma de decisiones en America Latina
[7]   Integration of real-world evidence from different data sources in health technology assessment [J].
Graili, Pooyeh ;
Guertin, Jason R. ;
Chan, Kelvin K. W. ;
Tadrous, Mina .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2023, 26 :11460
[8]  
Health Technology Assessment International (HTAi), 2020, Latin America Policy Forum
[9]   Design Thinking: Past, Present and Possible Futures [J].
Johansson-Skoeldberg, Ulla ;
Woodilla, Jill ;
Cetinkaya, Mehves .
CREATIVITY AND INNOVATION MANAGEMENT, 2013, 22 (02) :121-146
[10]   Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America [J].
Justo, Nahila ;
Espinoza, Manuel A. ;
Ratto, Barbara ;
Nicholson, Martha ;
Rosselli, Diego ;
Ovcinnikova, Olga ;
Marti, Sebastian Garcia ;
Ferraz, Marcos B. ;
Langsam, Martin ;
Drummond, Michael F. .
VALUE IN HEALTH, 2019, 22 (06) :739-749